Summary & Overview
CPT 87207: Smear with Special Stain for Intracellular Parasites
CPT code 87207 represents a specialized laboratory test that involves preparing and interpreting a smear from a primary specimen using special stains to identify inclusion bodies or intracellular parasites, including organisms such as malaria, kala azar, and herpes. This procedure is critical in the diagnosis of infectious diseases, enabling clinicians to detect pathogens that may not be visible with standard staining techniques. The code is widely recognized and utilized across the United States, reflecting its importance in clinical laboratory medicine.
Major national payers covering this service include Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare. The publication provides an overview of payer coverage, clinical context, and relevant policy updates for this laboratory service. Readers will gain insights into typical sites of service, associated clinical specialties, and common diagnoses linked to the use of CPT code 87207. The article also highlights related CPT codes and modifiers, offering a comprehensive view of how this procedure fits within broader laboratory and pathology billing practices. Benchmarks and regulatory considerations are discussed to inform stakeholders about current trends and requirements for laboratory testing involving special stains for intracellular pathogens.
CPT Code Overview
CPT code 87207 is used to report a laboratory procedure involving a smear from a primary source, with interpretation, utilizing a special stain to detect inclusion bodies or intracellular parasites such as malaria, kala azar, or herpes. This service is classified as a laboratory procedure and is typically performed in a laboratory setting (Place of Service 81). The code is essential for identifying infectious agents within cells, supporting accurate diagnosis and treatment decisions.
Clinical & Coding Specifications
Clinical Context
A patient presents to a clinic or hospital with symptoms suggestive of an infectious disease, such as fever, sore throat, cough, or diarrhea. The clinician suspects an intracellular infection (e.g., malaria, herpes, or other inclusion body-forming pathogens) and collects a specimen (such as blood, throat swab, or tissue sample). The specimen is sent to the laboratory (Place of Service 81) for analysis. Laboratory personnel perform a special stain on the smear to detect inclusion bodies or intracellular parasites, interpret the results, and report findings to the ordering provider. This workflow supports diagnosis and management of infections where intracellular pathogens are suspected.
Coding Specifications
-
Modifiers:
- Modifier
26: Used when reporting only the professional component (interpretation of the smear and stain) by a pathologist or qualified physician. - Modifier
TC: Used when reporting only the technical component (performance of the staining procedure and preparation of the smear) by the laboratory.
- Modifier
-
Associated Provider Taxonomies:
Taxonomy Code Specialty Name 291U00000XClinical Laboratory 207ZP0102XPathology 207Q00000XFamily Medicine Physician
These taxonomies represent the laboratory performing the test, the pathologist interpreting the results, and the family medicine physician who may order the test.
Related Diagnoses
-
J02.9: Acute pharyngitis, unspecified- Relevant when a patient presents with sore throat and infection is suspected; intracellular pathogens may be considered.
-
J18.9: Pneumonia, unspecified organism- Used when pneumonia is diagnosed but the causative organism is not yet identified; intracellular pathogens may be part of the differential.
-
A49.9: Bacterial infection, unspecified- Applied when a bacterial infection is suspected but not yet confirmed; special stains may help identify intracellular bacteria.
-
B37.9: Candidiasis, unspecified- Used when fungal infection is suspected; special stains may assist in identifying intracellular fungal elements.
-
R19.7: Diarrhea, unspecified- Relevant for patients with diarrhea where infectious causes, including intracellular parasites, are considered.
Related CPT Codes
-
87070: Culture, bacterial; any other source except urine, blood or stool- Used to identify bacterial pathogens from various specimen sources. May be ordered alongside
87207when both intracellular and extracellular pathogens are suspected.
- Used to identify bacterial pathogens from various specimen sources. May be ordered alongside
-
87177: Ova and parasites, direct smears, concentration and identification- Used for detection of parasites in specimens. Can complement
87207when parasitic infection is suspected.
- Used for detection of parasites in specimens. Can complement
-
87210: Smear, primary source with interpretation; wet mount for infectious agents- Used for wet mount preparations to detect infectious agents. May be used as an alternative or in conjunction with
87207depending on the suspected organism.
- Used for wet mount preparations to detect infectious agents. May be used as an alternative or in conjunction with
-
87491: Chlamydia trachomatis, amplified probe technique- Used for molecular detection of Chlamydia trachomatis. May be ordered separately if Chlamydia is suspected, not directly related to intracellular staining but part of infectious disease workup.
These codes are commonly used together or as alternatives based on the clinical scenario and suspected pathogens.
National Reimbursement Benchmarks
Medicare's national mean rate for CPT 87207 is $18.17, closely aligned with Cigna's mean rate of $18.36, and notably higher than the BUCA (average commercial) mean rate of $12.86. Among commercial payers, Blue Cross Blue Shield and Cigna both report mean rates above $15, while UnitedHealth Group is the lowest at $8.96.
Rate dispersion varies significantly across payers. Medicare shows the tightest range, with a difference of only $1.00 between the 75th and 25th percentiles, indicating minimal variation. In contrast, Blue Cross Blue Shield exhibits the widest spread, with a $13.00 difference between the 75th and 25th percentiles. Cigna also shows a substantial range of $10.83, while UnitedHealth Group and Aetna have narrower dispersions of $3.63 and $4.00, respectively.
The table and chart below present the full breakdown of national mean rates and percentile values for each payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.